Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
09/2003
09/18/2003US20030176343 Administering to the subject an amount of topors (protein) effective to inhibit the uncontrolled proliferation for therapy
09/18/2003US20030176342 Novel potassium channel
09/18/2003US20030176341 For use as an anti-viral, anti-tumour or immunomodulatory agent
09/18/2003US20030176340 For therapy of renal failure
09/18/2003US20030176338 Novel serine-threonine kinase
09/18/2003US20030176336 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes
09/18/2003US20030176334 Using vitronectin alpha v beta 3 antagonists, and particularly for inhibiting angiogenesis in inflamed tissues and in tumor tissues and metastases
09/18/2003US20030176332 Novel use of cytokine inhibitors
09/18/2003US20030176331 Having therapeutic, diagnostic, and preventative benefits, particularly as immunotoxins; for therapy of cancer
09/18/2003US20030176330 55562 and 21617, novel human proteins and methods of use thereof
09/18/2003US20030175996 Peptide fructose and complex thereof with binding protein
09/18/2003US20030175995 Compounds, antibodies, reagent kits, methods of producing antibodies, and methods of detecting analytes
09/18/2003US20030175969 Prevention infant blood disorders
09/18/2003US20030175937 Cathepsin O2 protease
09/18/2003US20030175934 Controlling cell differentiation, cell proliferation; anticancer agents
09/18/2003US20030175921 Complexing antigen, antibodies; immunoassay
09/18/2003US20030175900 Compositions and methods for the treatment of tumor
09/18/2003US20030175898 Isolated nucleic acids; immune response disease
09/18/2003US20030175895 Chemokine
09/18/2003US20030175894 Chemokine alpha-6
09/18/2003US20030175888 Discrete acyltransferases associated with type I polyketide synthases and methods of use
09/18/2003US20030175884 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
09/18/2003US20030175881 Nucleic acids encoding (poly) peptides having chips activity
09/18/2003US20030175880 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/18/2003US20030175879 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/18/2003US20030175878 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/18/2003US20030175877 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175876 a neurotrophin with biological activity on the central/peripheral nervous system cells; used for treating GDNF-responsive conditions such as alzhiemer's, parkinsons; device for nerve damage treatment
09/18/2003US20030175875 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175874 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/18/2003US20030175873 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175872 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175871 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175870 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175869 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175868 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175867 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175866 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/18/2003US20030175865 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/18/2003US20030175855 Human sdf-5 protein and compositions
09/18/2003US20030175840 Kit which detects ligand associated with nuclear factor kappa beta receptor for treating toxic shock, sepsis, inflammation and graft vs host disease
09/18/2003US20030175837 Anti-TNF antibodies and peptides of human tumor necrosis factor
09/18/2003US20030175816 Antibodies that bind TNF-alpha converting enzyme
09/18/2003US20030175805 Comprises winglesslint 8D (Wnt-8D) polypeptides for treating asthma, nervous system, psychological, alzheimer, cancer, cardiomyopathies, lung and kidney disorders; wound healing agents; tissue engineering
09/18/2003US20030175794 Compositions for isolating a cDNA encoding a membrane-bound protein
09/18/2003US20030175741 PCP-administered (phencyclidine/angel dust) chronic animal models; drug screening
09/18/2003US20030175725 Mycobacterial diagnostics
09/18/2003US20030175711 Comprises ordered and repetitive antigen or antigenic determinant array for developing vaccines for treatment of infectious diseases, allergies and cancer; microarrays
09/18/2003US20030175708 Nucleic acids and proteins from cenarchaeum symbiosum
09/18/2003US20030175682 Screening for papilloma viruses
09/18/2003US20030175681 Inhibition of CMV infection and dissemination
09/18/2003US20030175312 Novel mutant allergens
09/18/2003US20030175311 A protein encoded by DNA sequence, for protecting poultry; veterinary medicine
09/18/2003US20030175304 Recombinant dimeric envelope vaccine against flaviviral infection
09/18/2003US20030175290 Molecular antigen array
09/18/2003US20030175289 TIE ligands
09/18/2003US20030175281 Monoclonal antibodies that preferntially bind to proteins having cytolysis and immunogenic activity
09/18/2003US20030175280 Antagonists to chaperonin 10
09/18/2003US20030175278 Ubiquilin, a presenilin interactor and methods of using same
09/18/2003US20030175277 Administering mixtures of antigens and phospholipase inhibitors as antitumor or anticarcinogenic agents
09/18/2003US20030175276 Monoclonal antibodies used as antagonists vascular endothelial growth factors (VEGF); angiogenesis inhibitors; antitumor agents
09/18/2003US20030175275 Methods of treatment by multiple administration of chimeric anti-TNF antibodies
09/18/2003US20030175274 Polynucleotides codes for antibodies having amino acid sequences selected from complementary determining regions of variable peptides or single chain fragments, used as anticarcinogenic agents
09/18/2003US20030175273 Monoclonal antibodies which preferentially bind to chemokine receptors, used for immunotherapy, as antiinflammatory, aniticarcinogenic agents and for prophylaxis of respiratory system disorders or antiallergens
09/18/2003US20030175272 Re-activated T-cells for adoptive immunotherapy
09/18/2003US20030175271 VEGF activity inhibitor
09/18/2003US20030175270 Suppression of Janus kinase and signal transducers and acitavators of transcription (JAK/STAT), by administering monoclonal antibodies; immunology
09/18/2003US20030175269 Light and heavy chain peptides, used as antagonists of CD antigen or membrane proteins, for prophylaxis of autoimmune diseases
09/18/2003US20030175268 Method and pharmaceutical composition for preventing and/or treating systemic inflammatory response syndrome
09/18/2003US20030175267 Method for the treatment of inflammatory joint disease
09/18/2003US20030175252 Therapeutic compounds for ovarian cancer
09/18/2003US20030175250 Isolated peptides which bind to HLA molecules and uses thereof
09/18/2003US20030175212 Use of soluble gammadelta T cell receptors for regulating T cell function
09/18/2003US20030175208 Treating a cancer of the immune system
09/18/2003CA2813780A1 Genetic products differentially expressed in tumors and use thereof
09/18/2003CA2518695A1 Downregulation of ca 125 tumor antigen and uses thereof
09/18/2003CA2480962A1 Immunogenicity of glucan binding protein
09/18/2003CA2478683A1 Antibodies against cancer antigen tmeff2 and uses thereof
09/18/2003CA2478604A1 Cancer-linked gene as target for chemotherapy
09/18/2003CA2478593A1 Cancer-linked gene as target for chemotherapy
09/18/2003CA2478572A1 Variants of human kallikrein-2 and kallikrein-3 and uses thereof
09/18/2003CA2478415A1 A multifunctional complex for targeting specific phagocytosis of a target agent
09/18/2003CA2478413A1 Genetic products differentially expressed in tumors and use thereof
09/18/2003CA2478369A1 Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same
09/18/2003CA2478346A1 Specific ab1'-antibodies against tumour-associated antigen ca 125
09/18/2003CA2478317A1 Methods of preventing or treating disorders by administering an integrin .alpha.v.beta.3 antagonist in combination with an hmg-coa reductase inhibitor or a bisphosphonate
09/18/2003CA2478239A1 The prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents
09/18/2003CA2478177A1 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist
09/18/2003CA2478169A1 Human antibodies specific to kdr and uses thereof
09/18/2003CA2478116A1 Neoplasm specific antibodies and uses thereof
09/18/2003CA2478102A1 Antigens and their use as diagnostics and vaccines against species of plasmodium
09/18/2003CA2478082A1 Uses of monoclonal antibody 8h9
09/18/2003CA2478032A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/18/2003CA2478029A1 Monoclonal and polyclonal antibodies recognizing coagulase-negative staphylococcal proteins
09/18/2003CA2477932A1 Use of egfr transactivation inhibitors in human cancer
09/18/2003CA2477675A1 Immunizing composition and method for inducing an immune response against the .beta.-secretase cleavage site of amyloid precursor protein
09/18/2003CA2476938A1 Compositions and methods for preventing and treating cancer via modulating ube1l, isg15 and/or ubp43
09/18/2003CA2475735A1 Immunotherapeutics for biodefense
09/17/2003EP1344827A2 Antifreeze proteins from basidiomycetes
09/17/2003EP1344826A1 Materials comprising and methods of preparation and use for ribosome - inactivating proteins
1 ... 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 ... 1494